Showing 241-250 of 9130 results for "".
Consolidating Regulatory Penalties: Introducing MIPS
https://practicaldermatology.com/topics/practice-management/consolidating-regulatory-penalties-introducing-mips/21140/A new system will consolidate Meaningful Use, Value-Based Modifier, and PQRS into one program. Here's what you need to know.Pruritus: A Marker For Cancer?
https://practicaldermatology.com/topics/practice-management/pruritus-a-marker-for-cancer/21181/Though the relationship is well known, new studies validate concerns regarding the link between pruritus and malignancy.7 Tips to Track Your Dermatology Social Media Campaign
https://practicaldermatology.com/topics/practice-management/7-tips-to-track-your-dermatology-social-media-campaign/21373/Tracking your social media marketing campaign requires a sustained commitment but pays dividends.Melanoma Rates Rising in Young Adults: Are UV Lamps to Blame?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-rates-rising-in-young-adults-are-uv-lamps-to-blame/21644/New data suggest that the rate of melanoma among individuals age 18 to 39 is on the increase, with poor UV protection strategies implicated.Therapies in Practice: Barrier Repair as an Element of Psoriasis Management
https://practicaldermatology.com/topics/practice-management/therapies-in-practice-barrier-repair-as-an-element-of-psoriasis-management/21977/Data suggest psoriasis involves barrier damage; topical barrier repair may support clearance.Curing the Blues: Resolution of the Tyndall Effect Through Removal of a Misplaced NASHA Filler with Hyaluronidase
https://practicaldermatology.com/topics/general-topics/PD0509_11-php/22833/Implantation of NASHA fillers too superficially can produce the Tyndall effect. Besides aesthetic elegance, longevity after injection and an excellent safety record, a significant advantage of NASHA fillers is that they are reversible when misplaced.Assessing Clinical Options for Moderately Dysplastic Nevi Excised with Positive Margins
https://practicaldermatology.com/topics/skin-cancer-photoprotection/assessing-clinical-options-for-moderately-dysplastic-nevi-excised-with-positive-margins/20322/The latest data support the decision to monitor patients rather than re-excise when the pathology report confirms moderate dysplasia with positive margins.The Evidence for Slow- and Fast-growing Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/1109_06-php/22058/Recent findings support the existence of slow-growing melanomas, offering a possible explanation for anomalies in melanoma incidence reporting.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/videos/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.Perspective: Mental Health is Skin Health
https://practicaldermatology.com/topics/psoriasis/perspective-mental-health-is-skin-health/20799/The evidence is in: Mental well-being influences the skin.